Alternatives to Rexulti if you can't fill your prescription

Rexulti (brexpiprazole) works well for many patients managing major depressive disorder (MDD), schizophrenia, or Alzheimer's-related agitation. But when the pharmacy can't fill your prescription — whether due to stock issues, insurance denials, or the high cost of the brand-name drug — you may need to consider alternatives.

This is a conversation to have with your prescriber, not a decision to make on your own. But being informed going into that conversation helps. Here's what you should know about the most common alternatives to Rexulti.

Important: Don't stop Rexulti without talking to your doctor

Rexulti should not be stopped abruptly. Doing so can cause withdrawal-like symptoms and may lead to a rapid return of your underlying condition. If you're unable to fill your prescription for a few days, contact your prescriber right away. They may be able to provide samples or assist with locating supply.

What makes a good Rexulti alternative?

Rexulti works as a serotonin-dopamine activity modulator — it acts as a partial agonist at serotonin 5-HT1A and dopamine D2 receptors, and as an antagonist at 5-HT2A receptors. This unique profile makes it effective for depression augmentation, schizophrenia, and Alzheimer's agitation.

A good alternative should share enough of that mechanism to address your specific condition, while ideally being easier to access and potentially more affordable. Not all alternatives are appropriate for all indications — the right switch depends on why you're taking Rexulti.

Aripiprazole (Abilify) — The closest alternative

Aripiprazole is the most pharmacologically similar drug to Rexulti. Both are dopamine D2 partial agonists, which is why both work for schizophrenia and MDD augmentation. Aripiprazole has been around since 2002, is available as an inexpensive generic, and is widely stocked at virtually every pharmacy.

The main clinical difference: aripiprazole has higher intrinsic activity at D2 receptors, which can cause more activating effects and a higher rate of akathisia (restlessness) compared to Rexulti. Brexpiprazole was actually designed with lower D2 intrinsic activity to reduce akathisia. If you found aripiprazole caused restlessness in the past, your prescriber should weigh this carefully.

Cost advantage: Generic aripiprazole costs roughly $5–$88 per month — a fraction of Rexulti's $1,500+ list price.

Quetiapine (Seroquel) — For depression or schizophrenia

Quetiapine extended-release (Seroquel XR) is FDA-approved as an adjunctive treatment for MDD and for schizophrenia. It works through a different mechanism than Rexulti but is widely used for both indications. Generic quetiapine is widely available and significantly less expensive than Rexulti.

Trade-off: Quetiapine carries a higher risk of sedation, metabolic side effects (weight gain, blood sugar changes), and anticholinergic effects compared to Rexulti. It may be preferred if sedation is actually desired (e.g., for insomnia alongside depression).

Cariprazine (Vraylar) — A newer option

Vraylar (cariprazine) is another newer atypical antipsychotic used for schizophrenia and bipolar depression. Like Rexulti, it is a D2/D3 partial agonist with a favorable metabolic side effect profile. It is a brand-name drug and similarly priced to Rexulti, so it solves cost problems but may address pharmacy availability issues if your local pharmacy stocks it more reliably.

Risperidone (Risperdal) — For schizophrenia

For patients taking Rexulti specifically for schizophrenia, risperidone is a long-established generic alternative that is widely available and inexpensive. It works differently (as a D2 antagonist rather than partial agonist) and has a different side effect profile — including higher rates of movement-related side effects and elevated prolactin. It is not indicated for MDD augmentation.

For Alzheimer's agitation specifically

Rexulti received FDA approval in 2023 for agitation associated with Alzheimer's dementia — it was the first drug approved specifically for this indication. If cost or access to Rexulti is an issue for a dementia patient, options are more limited. Non-pharmacological interventions are often the first-line recommendation, and any medication substitution should be guided carefully by the patient's geriatric specialist or neurologist.

Before switching: try to find Rexulti first

Switching antipsychotics isn't trivial — it takes time, monitoring, and a careful cross-titration. If you're struggling with access rather than the medication itself, it may be worth investing a little effort to locate Rexulti before switching. See our guide on how to find Rexulti in stock near you and our guide to saving money on Rexulti — you may find that cost or access barriers can be resolved without changing your medication.